Video: Jim Cramer on the Eagles, Celgene, Juno Therapeutics and Netflix

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts to Monday's trending topics including the Philadelphia Eagle's Sunday victory, Celgene's (CELG) - Get Report plans to buy Juno Therapeutics (JUNO) and what to expect from Netflix's (NFLX) - Get Report upcoming quarterly earnings. 

Want more exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here: